 Two Sigma Advisers LP lessened its position in shares of Aclaris Therapeutics Inc NASDAQ:ACRS by 40.1 in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,700 shares of the biotechnology companys stock after selling 23,200 shares during the period. Two ... 